Unveiling Key Facts About Cooper Stock

By Tamara Parker • Friday, March 01 10:13 • Permanent Link

Large-cap Health Care company The Cooper has moved 6.9% so far today on a volume of 743,061, compared to its average of 1,113,846.

The Cooper trades 2.32% away from its average analyst target price of $97.79 per share. The 15 analysts following the stock have set target prices ranging from $82.5 to $110.0, and on average have given The Cooper a rating of buy.

If you are considering an investment in COO, you'll want to know the following:

The Cooper has moved 6.4% over the last year, and the S&P 500 logged a change of 26.0%
Based on its trailing earnings per share of 1.48, The Cooper has a trailing 12 month Price to Earnings (P/E) ratio of 67.6 while the S&P 500 average is 15.97
COO has a forward P/E ratio of 25.7 based on its forward 12 month price to earnings (EPS) of $3.89 per share
The company has a price to earnings growth (PEG) ratio of 2.73 — a number near or below 1 signifying that The Cooper is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 2.6 compared to its sector average of 4.08
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
Based in San Ramon, the company has 15,000 full time employees and a market cap of $19.89 Billion. The Cooper currently returns an annual dividend yield of 0.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.